# Zemplar

NDC: 0074-1658
Generic name: Paricalcitol
Labeler / Manufacturer: AbbVie Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: INJECTION, SOLUTION
Routes: INTRAVENOUS
Marketing started: 19980417

FDA application: NDA020819

## Active ingredients

- PARICALCITOL: 5 ug/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0074-1658"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0074-1658
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=7259652f-81bc-4ad1-bba5-d01f9fac1b80